Laura Gover, Andrew Anguko, Jane Bruce, Godfrey Magumba, et al.
1
Lee, V.
1
Lenzen, M.
1
Leon-Velarde, F.
1
Lesotho National AIDS Commission, Government of Lesotho
1
Llyod, A.
1
London School of Hygiene and Tropical Medicine
1
López, L.
1
Lucinda Ramos
1
Lukito, A.A., A.U. Rahajoe, L.I. Rilantono, et al.,
1
M. A. Babu
1
M. B. Mello
1
M. Bertram et al.
1
M. Doara, D. Choroliani, P. de Colombani
1
M. Doherty
1
M. F. Silveira
1
M. Gallardo, et al.
1
M. Holtmann
1
M. Joffres
1
M. Kan
1
M. M. Ahmmed
1
M. Odhiambo Sewe, A.M Tompkins et al.
1
M. Penazzato
1
M. R. Jordan
1
M. Semrau
1
M. Smelyanskaya, J. Duncan
1
M. Sundararaj
1
M. Vitoria
1
M.C. Mollo, et al.
1
M.Johnson
1
M.N. Ngongondo
1
Machalaba
1
MacQuarrie, Kerry L.D., Rebecca Winter, and Sunita Kishor
1
MacQuarrie, Kerry L.D., Sarah E.K. Bradley, Alison Gemmill, and Sarah Staveteig
1
Magitta, N.F.
1
Mailloux, N.A. et al.
1
Mairie de Paris
1
Makatjane, T. J., T. Hlabana, and E. M. Letete
1
Malaria Consortium
1
Malik, A. A.
1
Mangwiro, TNC.
1
March of Dimes
1
Mark W. Rosegrant | Jawoo Koo | Nicola Cenacchi
1
Marselle M., Stadler J., Korn H., et al.
1
Martinez, L.
1
Martínez-Austria Polioptro,F and Bandala E. R
1
Mary De Silva, Lucy Lee& Grace Ryan
1
Mary-Anne Hartley, Alyssa Young, Anh-Minh Tran et al.
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Massoda Tonye, S.G.
1
Matsushita, K.
1
Maurice Bucagu, Jean M. Kagubare, Paulin Basinga, Fidèle Ngabo, Barbara K Timmons & Angela C Lee
1
McCullagh S, Hunter B, Houle K et al.
1
McGahey, Christopher
1
McGloin, J.
1
MCNV, Global Initiative on Psychiatry, and World Granny
1
Mediscript Ltd
1
Melanie Duncan, et al.
1
Mensah, G.A.
1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
1
Meyfroidt, P.
1
Médecins Sans Frontières (MSF)
1
Médecins sans Frontières MSF
1
mhGAP
1
Michael T. Osterholma, Kristine A. Moorea, Nicholas S. Kelley et al.
1
Miller, C.
1
Ministerio de sanidad - España
1
Ministry of Health & Child Welfare
1
Ministry of Health & Family Welfare, India, et al.
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Directorate-General of Health Services, Mycobacterial Disease Control, National Tuberculosis Control Programme
1
Ministry of Health and Social Services (MOHSS)
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health Ethiopia
1
Ministry of Health, Gabarone, Botswana
1
Ministry of Health, Ghana
1
Ministry of Health, Pakistan
1
Ministry of Health, Republic of South Africa
1
Ministry of Health, Republic of Uganda
1
Ministry of Health, South Africa
1
Ministry of Health, Uganda
1
Ministry of Health, Zambia
1
Ministry of Public Health, Quatar
1
Minja, N.W.
1
Mock C. N., Nugent R. et. al.
1
Mock, Charles N.
1
Mohammed A. , Putnis N. et al.
1
Monnier, N.
1
Mont, D.
1
Montelongo, A.
1
Moo-llanes, D.
1
Mortimer, K.
1
Moses, M.W.
1
MSF Access Campaign
1
MSMGF
1
Mukaratirwa, S. et al.
1
Murray, C.J.L.
1
Mutale W.
1
Myanmar Climate Change Alliance (MCCA)
1
Myanmar, Ministry of Health and Sports
1
N. Abera, T. Saballa, et al.
1
N. B. Ahmed
1
N. K. Arora
1
N.I. Agudelo Higuita, S.A. Hamer, et al.
1
NACO, Department of AIDS Control
1
Nakagaayi, D.
1
NASCOP
1
Nat Commun 13, 2788 (2022)
1
National Academy of Sciences of the USA
1
National Agency for Control of AIDS (NACA)
1
National AIDS
1
National AIDS Control Program
1
National AIDS Secretariat
1
National Department of Health South Africa
1
National HIVAIDS Council Zambia
1
National Institute of Disaster Management (NIDM), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
1
National Institute of Environmental Health Sciences
1
National Malaria Elimination Centre, Ministry of Health, Zambia
1
National TB Control Programme, Bangladesh
1
Nature Communications
1
nature medicine
1
Nature Scientific Reports
1
Ncube, M.
1
ndia State-Level Disease Burden Initiative Cancer Collaborators
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Net Hope
1
Niederberger, E.
1
Norwegian Red Cross
1
Norwegian Refugee Council, Internal Displacement Monitoring Centre
1
Nouvellet, P.
1
Nove A., Friberg I., de Bernis L., et al.
1
NSW Health and University of Western Sydney
1
Nugent, Rachel
1
Nunn, Marc
1
Nunziata, K. R.
1
O. Hanssen
1
O. Samoylova
1
O. T. Ranzani
1
OECD
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Oliveira, R.G. de.
1
Olney, Jack J.
1
OMS (WHO)
1
ONUSIDA
1
Organización Mundial de Saude and OPAS
1
Organização Mundial da Saúde (OMS)
1
Ouédraogo M., Samadoulougou S., Rouamba T. et. al.
La prise en charge de la tuberculose représente un véritable défi en milieu carcéral et l’organisation de la continuité des soins à la sortie un enjeu majeur. Comme tout être humain, les détenus ont le droit de jouir du meilleur état de santé physique et mental possible. Ce droit est gar...anti par l’article 25 de la Déclaration universelle des droits de l’homme adoptée par l’Organisation des Nations Unies, et par l’article 12 du Pacte international relatif aux droits économiques, sociaux et culturels. Ce travail fait un état des lieux sur la prise en charge de la tuberculose en milieu carcéral au Sénégal, depuis les stratégies de dépistage jusqu’à la continuité des soins après la sortie de prison.more
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...nded eligibility for antiviral prophylaxis for pregnant women to prevent mother-to-child transmission of HBV; improving HBV diagnostics through use of point-of-care HBV DNA viral load and reflex approaches to HBV DNA testing; who to test and how to test for HDV infection; and approaches to promote delivery of high-quality HBV services, including strategies to promote adherence to long-term antiviral therapy and retention in care.
The 2024 guidelines include 11 updated chapters with new recommendations and also update existing chapters without new recommendations, such as those on treatment monitoring and surveillance for liver cancer.more
La prise en charge de la tuberculose représente un véritable défi en milieu carcéral et l’organisation de la continuité des soins à la sortie un enjeu majeur. Comme tout être humain, les détenus ont le droit de jouir du meilleur état de santé physique et mental possible. Ce droit est gar...anti par l’article 25 de la Déclaration universelle des droits de l’homme adoptée par l’Organisation des Nations Unies, et par l’article 12 du Pacte international relatif aux droits économiques, sociaux et culturels. Ce travail fait un état des lieux sur la prise en charge de la tuberculose en milieu carcéral au Sénégal, depuis les stratégies de dépistage jusqu’à la continuité des soins après la sortie de prison.more
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells... of the germ layers, oncogenic potential, unrecognised toxicities and possible involvement in pre-implantation stages of human development. The guideline therefore focuses on: 1. Monitoring mechanism and regulatory pathway for basic, clinical research and product development based on categories of research and level of manipulation. 2. Procurement of gametes, embryos and somatic cells for derivation and propagation of any stem cell lines, their banking and distribution. 3. Other important areas like international collaboration, exchange of cell/lines and education for stakeholders and advertisement.more
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...xtensively drug-resistant tuberculosis.more
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...ealth workers can contribute to improving hypertension detection and management.more
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...is also provided to standardize monitoring and public reporting of variant circulation.
The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variantsmore
The guide is divided into 3 sections —the first focuses on the conceptual framework for M&E; the second focuses on six key steps for M&E; and further, the appendix provides additional tools, resources, and projects for M&E. With a comprehensive breakdown of the important approaches as well as a ch...ecklist approach to the setting up of a monitoring and evaluation framework, this guide works for almost everyonemore
The Core Set of Indicators and respective Indicator Data Sheets aim to pave the way towards a common understanding, greater consistency and comparability across countries and alignment of results chains of German Development Cooperation in the field of health and social health protection with the in...ternationally recognized health systems framework of WHO and International Health Partnership (IHP+).more
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in... order to make evidence-based decisions on the most appropriate control measures for each specific situation. IVM can be used for surveillance and control or for elimination of VBDs and can help reduce the development of insecticide resistance through the rational use of these products. This document provides instructions for fulfillment of the 2008 PAHO mandate set forth in CD 48/13 (Integrated Vector Management).more
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov...ide population-wide access to essential medicines.
Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products.
This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.more
Vector control is a vital component of malaria prevention, control and
elimination strategies because it can be highly effective in providing
personal protection and/or reducing disease transmission.